You Searched for International Treatments For Metatastic Prostate Cancer, Here is an Article Related to International Treatments For Metatastic Prostate Cancer
International Treatments For Metatastic Prostate Cancer Article
. You may Bookmark this article or link to it permanently - ,click here.
The Prostate and Its Foe
********The prostate is situated at the exit of the bladder where the urethra (tube that carries urine) leaves. It is wrapped around the urethra and is slightly smaller than a golf ball.
The role of the prostate is to produce the watery liquid that is mixed with sperm and is found during ejaculation. This fluid is used to lubricate the sperm and to help them on their journey up the woman's cervix.
The prostate is made up of four zones, which make up different amounts of the prostate and have different effects, as can be seen below.
The peripheral zone
This zone makes up about seventy percent of the glandular area of the prostate. It is also the back of the prostate that wraps around the urethra and sits against the outer wall of the rectum. This zone is where at least seventy percent of all prostate cancer starts.
The central zone
The central zone accounts for roughly twenty-five percent of the gland part of the prostate and surrounds the ducts used during ejaculation. This area accounts for about twenty-five percent of all prostate cancers.
The transition zone
This zone makes up only five percent of the prostate, but is the only area of the prostate gland that carries on growing throughout a man's life. The transition zone surrounds the urethra and is the general contributory factor to benign prostatic enlargement.
The anterior fibro muscular zone
The anterior fibro muscular zone makes up about five percent of the prostate's weight and is made up of muscle and tissue that is fibrous in nature. This area does not really affect the human host with any conditions.
The effects a condition in the prostate can have vary greatly between different men, but there are generalized symptoms that many people complain of when going to visit their doctor. These symptoms include pain while urinating, blood in the urine, difficulty passing urine, and worst of all, impotence or erectile dysfunction (problems getting and keeping an erection).
The three main culprits for these symptoms are prostate cancer, prostatitis, and benign prostatic hyperplasia. Prostate cancer and benign prostatic hyperplasia generally only affects the men who are more senior in age but prostatitis can affect anyone from the male population.
Taking simple antibiotic medication can treat most conditions, but in more serious cases, surgical procedures can be the only outcome in trying to combat the problems people face.
The problem with prostate conditions, like many conditions that affect the sexual organs in the male is man's pride. Males tend to have a certain connection with their "male" anatomy that causes them to find it difficult to visit a doctor or nurse about any issues they are having, even if these problems are quite bad.
If you suffer any symptoms that you feel may be related to a prostate problem it is important that you seek medical advice quickly, You never know what may be the problem may be and what trouble it may cause you.
International Treatments For Metatastic Prostate Cancer Specific links
International Treatments For Metatastic Prostate Cancer News
Experimental Drug Benefits Patients with Advanced Prostate Cancer - NCI Cancer Bulletin
![]() Daily Mail | Experimental Drug Benefits Patients with Advanced Prostate Cancer NCI Cancer Bulletin The international TROPIC (Treatment of Hormone-Refractory Metastatic Prostate Cancer Previously Treated with a Taxotere-Containing Regimen) study included ... GU Cancers Symposium 2010: ASCO ASTRO SUO - Prostate cancer: Screening and ... |
Molecular Insight Pharmaceuticals Reports Fourth Quarter and Year-End 2009 ... - CNNMoney.com (press release)
Molecular Insight Pharmaceuticals Reports Fourth Quarter and Year-End 2009 ... CNNMoney.com (press release) Trofex has the potential to both detect and, when labeled with a therapeutic isotope, to treat metastatic prostate cancer. Clinical data from this trial ... |
GTx Provides Corporate Update and Reports 2009 Financial Results - MarketWatch (press release)
GTx Provides Corporate Update and Reports 2009 Financial Results MarketWatch (press release) In late February, the last patient completed the Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in high risk men ... |
Med professor tests new drug to prolong lives of prostate cancer patients - The Hullabaloo Online
Med professor tests new drug to prolong lives of prostate cancer patients The Hullabaloo Online The major international trial of this drug is called the “treatment of hormone-refractory metastatic prostate cancer previously treated with a ... |
Sanofi drug boosts prostate cancer survival 30 pct - Reuters
![]() eFitnessNow | Sanofi drug boosts prostate cancer survival 30 pct Reuters Other studies are planned to assess the effectiveness of Jevtana earlier in the course of prostate cancer treatment, before patients stop responding to ... Tulane Cancer Researcher leads trial for promising prostate cancer therapy Sanofi Drug Raises Prostate Cancer Survival Rates By 30% |
Caring for Patients With Cancer - Journal of American Medical Association (subscription)
Caring for Patients With Cancer Journal of American Medical Association (subscription) Four studies in this issue of JAMA report research findings on treatment outcomes for colon, prostate, liver, and lung cancer. ... |
Studies Presented At 2010 Genitourinary Cancers Symposium Advance Management ... - Medical News Today (press release)
Studies Presented At 2010 Genitourinary Cancers Symposium Advance Management ... Medical News Today (press release) Investigational chemotherapy drug increases survival for advanced prostate cancer: An international phase III clinical trial reports that a new chemotherapy ... |



